Cat. No. |
Product Name |
Information |
PC-62061 |
BZ-194
|
BZ-194 is a small molecule inhibitor of NAADP action that inhibit NAADP-mediated Ca2+ signaling in T cells, neither interferes with Ca2+ mobilization by IP3 or cyclic ADP-ribose nor with capacitative Ca2+ entry. |
PC-62033 |
LCS-1.34
|
LCS-1.34 is a small molecule that inhibits growth of human lung adenocarcinoma cells harboring mutations in EGFR or KRAS with IC50 of 0.1-1.1 uM. |
PC-62032 |
LCS-1.28
|
LCS-1.28 is a small molecule that inhibits growth of human lung adenocarcinoma cells harboring mutations in EGFR or KRAS with IC50 of 0.05-1.6 uM. |
PC-62031 |
LCS-1
|
LCS-1 is a small molecule that inhibits growth of human lung adenocarcinoma cells harboring mutations in EGFR or KRAS with IC50 of 0.1-1.5 uM. |
PC-62025 |
FQI2
|
FQI2 is a small-molecule inhibitor of transcription factor LSF with IC50 of 0.71 uM. |
PC-62024 |
(S)-FQI1
|
(S)-FQI1 is a small-molecule inhibitor of transcription factor LSF with IC50 of 0.93 uM, approximately 2-fold more active than the racemate FQI-1. |
PC-62023 |
FQI1
|
FQI1 is a small-molecule inhibitor of transcription factor LSF with IC50 of 2.1 uM. |
PC-61918 |
Cyclocreatine Phosphate
|
Cyclocreatine Phosphate (AM 285) is an analog of the creatine kinase CKMT1 substrate creatine and inhibitor of the creatine biosynthesis pathway. |
PC-61883 |
PF-03382792
|
PF-03382792 (PF-3382792) is a clinical compound under phase 1 investigation for an unknown indication.. |
PC-61856 |
EPI 743
|
EPI 743 (Vatiquinone) is an orally bioavailable para-benzoquinone for treatment of inherited mitochondrial diseases, an analogue of the antioxidant ubidecarenone.. |
PC-61820 |
UK-396082
|
UK-396082 is a potent and selective inhibitor of activated thrombin-activatable fibrinolysis inhibitor (activated TAFI. |
PC-61795 |
Cromoglicic acid
|
Cromoglicic acid is a mast cell stabilizer with anti-inflammatory activity that prevents the release of inflammatory chemicals such as histamine, leukotrienes from mast cells. |